1995
DOI: 10.1016/0264-410x(95)00117-j
|View full text |Cite
|
Sign up to set email alerts
|

Interferon-γ inductive effect of liposomes as an immunoadjuvant

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
11
0
1

Year Published

1997
1997
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(13 citation statements)
references
References 22 publications
1
11
0
1
Order By: Relevance
“…The immunoadjuvant activity of liposomes has been established in a large number of studies (Gregoriadis, 1990;Gregoriadis et al, 2000;Tanaka et al, 2004;Kim et al, 2000;Aramaki et al, 1995;de Haan et al, 1995;Alving et al, 1995;Antimisiaris et al, 1993). Liposomes containing both antigen and adjuvant have been proposed as carriers for vaccines (Alving, 1991).…”
Section: Introductionmentioning
confidence: 95%
“…The immunoadjuvant activity of liposomes has been established in a large number of studies (Gregoriadis, 1990;Gregoriadis et al, 2000;Tanaka et al, 2004;Kim et al, 2000;Aramaki et al, 1995;de Haan et al, 1995;Alving et al, 1995;Antimisiaris et al, 1993). Liposomes containing both antigen and adjuvant have been proposed as carriers for vaccines (Alving, 1991).…”
Section: Introductionmentioning
confidence: 95%
“…First, adjuvants are known to augment a particular differentiation toward Th1 or Th2 responses, and the use of adjuvants requires great care in the modulating of immune responses. Aluminum hydroxide (alum, Al(OH) 3 ) and diesel‐exhaust particulates are known to act as adjuvants to induce Th2 responses preferentially in rodents (23, 25, 30). Thus, the use of adjuvants makes the difference in the optimal dose of the ability of Ag to induce an immune reaction.…”
Section: Discussionmentioning
confidence: 99%
“…Hence, subunit vaccines require a careful formulation to be fully effective, often based on the use of strong adjuvants and/or immunostimulating molecules. [43][44][45][46][47][48][49] In order to improve immune system responsiveness, antigens can be conjugated to carrier proteins, e.g., bacterial tossoids or high molecular weight proteins, giving rise to large molecules which are more effectively presented to immune system. Such an approach is also adopted in carbohydrate vaccine technology.…”
Section: Subunit Vaccinesmentioning
confidence: 99%